NCT00004474View on ClinicalTrials.gov

Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Aplastic Anemia
Interventions
DRUG

Anti-thymocyte globulin

Given via IV over 4 hours

DRUG

Cyclophosphamide

Given via IV over 60 minutes on Days -5 to -2

PROCEDURE

Bone marrow transplantation

Given on Day 0

Trial Locations (4)

53226

Medical College of Wisconsin, Milwaukee

Midwest Children's Cancer Center, Milwaukee

14263-0001

Roswell Park Cancer Institute, Buffalo

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00004474 - Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia | Biotech Hunter | Biotech Hunter